Xenon Pharmaceuticals XENE
NASDAQ XENE
$59.58 -0.82 (-1.36%)
As of: Sep 4, 2026 · 2:25 PM EDT

Xenon Pharmaceuticals (XENE) EPS (Diluted) (2013 - 2026)

Analysis

Xenon Pharmaceuticals (XENE) EPS (Diluted) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 12.23
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 7.15
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.07 Bn 44.07 Bn - -3.06
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.42 Bn 27.58 Bn - 0.15
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -0.06
10 Xenon Pharmaceuticals 5.93 Bn 5.93 Bn - -1.11
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.11
Mar 31, 2026 -1.17
Dec 31, 2025 -0.74
Sep 30, 2025 -1.15
Jun 30, 2025 -1.07
Mar 31, 2025 -0.83
Dec 31, 2024 -1.02
Sep 30, 2024 -0.81
Jun 30, 2024 -0.75
Mar 31, 2024 -0.62
Dec 31, 2023 -0.67
Sep 30, 2023 -0.73
Jun 30, 2023 -0.72
Mar 31, 2023 -0.63
Dec 31, 2022 -0.62
Sep 30, 2022 -0.57
Jun 30, 2022 -0.55
Mar 31, 2022 -0.35
Dec 31, 2021 -0.57
Sep 30, 2021 -0.36